AVATASCAN

AVATASCAN® IS AN AUTOMATED DRUG SCREENING SYSTEM OF PATIENT-DERIVED SAMPLES. IT COMPRISES A ROBOTIC SYSTEM FOR RAPID SCREENING OF DRUG PANEL ON PATIENTS’ SAMPLES. IT IS DEPLOYED TO AVATAMED PRECISION ONCOLOGY SERVICES, THE AVATA PANCANCER 60 TEST, WHICH INTEGRATES GENE-DRUG RESPONSES AND GENOMIC ANALYSIS TO SUGGEST THE MOST OPTIMAL TREATMENT OPTION FOR THE PATIENTS.

AVATASCAN® is an automated drug screening system of patient-derived samples. It comprises a robotic system for rapid screening of drug panel on patients’ samples. It is
deployed to AVATAMED precision oncology services, the AVATA PanCancer 60 test, which integrates gene-drug responses and genomic analysis to suggest the most optimal
treatment option for the patients.

AVATASCAN® CAN ALSO BE APPLIED TO DRUG DISCOVERY AND DEVELOPMENT, AS WELL AS VIRTUAL CLINICAL TRIALS PRIOR TO PHASE 2 CLINICAL TRIALS AND BEYOND. TOGETHER WITH OTHER AVATAR PLATFORMS, IT WILL ACCELERATE AND ADVANCE DRUG DEVELOPMENT. WE WELCOME COLLABORATIONS WITH RESEARCHERS AND PHARMACEUTICAL COMPANIES. PLEASE REACH OUT TO US AT AVATAMED@AVATAMED.COM.

AVATASCAN® can also be applied to drug discovery and development, as well as virtual clinical trials prior to Phase 2 clinical trials and beyond. Together with other AVATAR platforms, it
will accelerate and advance drug development. We welcome collaborations with Researchers and Pharmaceutical
Companies. Please reach out to us at avatamed@avatamed.com.